Problem

Slingshot AI targets the access gap in mental-health care: nearly 40% of Americans live in areas with a shortage of mental-health professionals, while therapists report substantial latent demand from people on waiting lists. That demand is not limited to diagnosed illness; it includes stress, loneliness, sadness, relationship and job changes, healthy-habit formation, and post-discharge support. The economic pain is a mismatch between scarce, expensive human capacity and a large volume of people who need timely, lower-acuity support but may not be able to obtain an appointment.

The killer use case is an always-available, private place to talk through everyday emotional problems—especially stress, anxiety, relationships, or a bad day—without waiting for a therapist. Slingshot positions this as an accessible supplement to professional care, not a crisis service or replacement for diagnosis and treatment.

Product / Service

The product is Ash, a consumer mental-health app delivered through voice and text on mobile. Users can speak or message Ash 24/7; the system is designed to identify patterns across conversations, connect thoughts, feelings, and behaviors, remember a user’s history and progress, and provide weekly insights and personalized next steps. Ash is built on Slingshot’s psychology-focused foundation-model research rather than being a general-purpose chatbot repurposed for therapy.

Slingshot says Ash is trained on proprietary expert and behavioral-health data and incorporates approaches including cognitive behavioral therapy, dialectical behavior therapy, acceptance and commitment therapy, psychodynamic therapy, and motivational interviewing. Its intended benefit is scalable, low-friction support that can adapt its therapeutic style to the user and moment. The app launched as a free iOS and Android service, although the App Store listing indicates in-app purchases; it explicitly warns that Ash is not for emergencies and can make mistakes.

Market

Slingshot competes in consumer mental-health AI and the broader digital behavioral-health market, alongside AI therapy and wellness products such as Wysa and Woebot. Its claimed differentiation is a specialist model trained for therapeutic interaction: unlike general-purpose assistants designed mainly to answer and appease, Ash is intended to know when to listen, challenge a perspective, or guide a user toward personal insight. Human therapy remains the higher-acuity substitute and an important source of clinical credibility, while the company’s product is aimed primarily at accessible, ongoing support.

The company is launched and has meaningful early traction rather than being pre-product. Slingshot reported 50,000 beta users before Ash’s July 2025 public launch; subsequent reporting said more than 150,000 people had used it, and the current Ash site displays 15.7 million messages and 250,000 people helped. It raised $93 million by July 2025, including an extension of its Series A led by Radical Ventures and Forerunner Ventures. The research reviewed does not establish revenue or a settled long-term monetization model, so the strongest public evidence today is usage and fundraising rather than disclosed commercial revenue.